Related references
Note: Only part of the references are listed.Cognitively unimpaired adults' reactions to disclosure of amyloid PET scan results
Emily A. Largent et al.
PLOS ONE (2020)
Development of memory clinics in the Netherlands over the last 20 years
Angelique A. A. Gruters et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2019)
Assessment of the appropriate use criteria for amyloid PET in an unselected memory clinic cohort: The ABIDE project
Arno de Wilde et al.
ALZHEIMERS & DEMENTIA (2019)
On the reconceptualization of Alzheimer's disease
Maartje H. N. Schermer et al.
BIOETHICS (2019)
A critical appraisal of amyloid-βtargeting therapies for Alzheimer disease
Francesco Panza et al.
NATURE REVIEWS NEUROLOGY (2019)
Practice guideline update summary: Mild cognitive impairment: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology
Ronald C. Petersen et al.
NEUROLOGY (2018)
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2018)
The End of the Beginning of the Alzheimer's Disease Nightmare: A Devil's Advocate's View
Anders Wimo
JOURNAL OF ALZHEIMERS DISEASE (2018)
Comprehension of an Elevated Amyloid Positron Emission Tomography Biomarker Result by Cognitively Normal Older Adults
Jessica Mozersky et al.
JAMA NEUROLOGY (2018)
On the personal utility of Alzheimer's disease-related biomarker testing in the research context
Eline M. Bunnik et al.
JOURNAL OF MEDICAL ETHICS (2018)
Gatekeeping and trailblazing: The role of biomarkers in novel guidelines for diagnosing Alzheimer's disease
Marianne Boenink
BIOSOCIETIES (2018)
Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers
Giovanni B. Frisoni et al.
LANCET NEUROLOGY (2017)
The usual suspects: why techno-fixing dementia is flawed
Karin Rolanda Jongsma et al.
MEDICINE HEALTH CARE AND PHILOSOPHY (2017)
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
Bruno Dubois et al.
ALZHEIMERS & DEMENTIA (2016)
Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia A Meta-analysis
Willemijn J. Jansen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
The relative contributions of disease label and disease prognosis to Alzheimer's stigma: A vignette-based experiment
Rebecca Johnson et al.
SOCIAL SCIENCE & MEDICINE (2015)
Development of a process to disclose amyloid imaging results to cognitively normal older adult research participants
Kristin Harkins et al.
ALZHEIMERS RESEARCH & THERAPY (2015)
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
Bruno Dubois et al.
LANCET NEUROLOGY (2014)
The A4 Study: Stopping AD Before Symptoms Begin?
Reisa A. Sperling et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
The War (on Terror) on Alzheimer's
Daniel R. George et al.
DEMENTIA-INTERNATIONAL JOURNAL OF SOCIAL RESEARCH AND PRACTICE (2014)
Appropriate use criteria for amyloid PET: A report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association
Keith A. Johnson et al.
ALZHEIMERS & DEMENTIA (2013)
MRI and cerebrospinal fluid biomarkers for predicting progression to Alzheimer's disease in patients with mild cognitive impairment: a diagnostic accuracy study
Edo Richard et al.
BMJ OPEN (2013)
Political drive to screen for pre-dementia: not evidence based and ignores the harms of diagnosis
David G. Le Couteur et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Should we disclose amyloid imaging results to cognitively normal individuals?
Joshua D. Grill et al.
NEURODEGENERATIVE DISEASE MANAGEMENT (2013)
Frames and counter-frames giving meaning to dementia: A framing analysis of media content
Baldwin Van Gorp et al.
SOCIAL SCIENCE & MEDICINE (2012)
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Reisa A. Sperling et al.
ALZHEIMERS & DEMENTIA (2011)
The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Marilyn S. Albert et al.
ALZHEIMERS & DEMENTIA (2011)
Metaphors We Think With: The Role of Metaphor in Reasoning
Paul H. Thibodeau et al.
PLOS ONE (2011)
The living dead? The construction of people with Alzheimer's disease as zombies
Susan M. Behuniak
AGEING & SOCIETY (2011)
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Clifford R. Jack et al.
LANCET NEUROLOGY (2010)
Molecular medicine and concepts of disease: the ethical value of a conceptual analysis of emerging biomedical technologies
Marianne Boenink
MEDICINE HEALTH CARE AND PHILOSOPHY (2010)
Amyloid imaging in aging and dementia: Testing the amyloid hypothesis in vivo
G. D. Rabinovici et al.
BEHAVIOURAL NEUROLOGY (2009)
Research criteria for the diagnosis of Alzheimers disease: revising the NINCDS-ADRDA criteria
Bruno Dubois et al.
LANCET NEUROLOGY (2007)
The case of the missing person: Alzheimer's disease in mass print magazines 1991-2001
JN Clarke
HEALTH COMMUNICATION (2006)
Share Paper
